Legal & General Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $639K | Buy |
6,685
+94
| +1% | +$8.56K | ﹤0.01% | 2323 |
|
|
2026
Q1 | $634K | Sell |
6,591
-1,387
| -17% | -$139K | ﹤0.01% | 2293 |
|
|
2025
Q4 | $776K | Sell |
7,978
-2,032
| -20% | -$174K | ﹤0.01% | 2286 |
|
|
2025
Q3 | $712K | Hold |
10,010
| – | – | ﹤0.01% | 2333 |
|
|
2025
Q2 | $598K | Buy |
10,010
+1,905
| +24% | +$104K | ﹤0.01% | 2394 |
|
|
2025
Q1 | $425K | Sell |
8,105
-575
| -7% | -$32.3K | ﹤0.01% | 2445 |
|
|
2024
Q4 | $477K | Sell |
8,680
-855
| -9% | -$45K | ﹤0.01% | 2471 |
|
|
2024
Q3 | $480K | Buy |
9,535
+334
| +4% | +$15.4K | ﹤0.01% | 2478 |
|
|
2024
Q2 | $404K | Buy |
9,201
+135
| +1% | +$5.74K | ﹤0.01% | 2488 |
|
|
2024
Q1 | $399K | Hold |
9,066
| – | – | ﹤0.01% | 2514 |
|
|
2023
Q4 | $430K | Buy |
9,066
+249
| +3% | +$10.5K | ﹤0.01% | 2517 |
|
|
2023
Q3 | $391K | Buy |
8,817
+7,567
| +605% | +$352K | ﹤0.01% | 2529 |
|
|
2023
Q2 | $59.7K | Buy |
1,250
+360
| +40% | +$16.2K | ﹤0.01% | 2859 |
|
|
2023
Q1 | $35K | Hold |
890
| – | – | ﹤0.01% | 2932 |
|
|
2022
Q4 | $25.2K | Hold |
890
| – | – | ﹤0.01% | 3102 |
|
|
2022
Q3 | $27K | Buy |
890
+125
| +16% | +$4.35K | ﹤0.01% | 3129 |
|
|
2022
Q2 | $26K | Buy |
765
+88
| +13% | +$3.15K | ﹤0.01% | 3151 |
|
|
2022
Q1 | $30K | Buy |
677
+5
| +0.7% | +$231 | ﹤0.01% | 3125 |
|
|
2021
Q4 | $31K | Hold |
672
| – | – | ﹤0.01% | 3139 |
|
|
2021
Q3 | $23K | Buy |
672
+34
| +5% | +$1.16K | ﹤0.01% | 3226 |
|
|
2021
Q2 | $19K | Hold |
638
| – | – | ﹤0.01% | 3309 |
|
|
2021
Q1 | $16K | Sell |
638
-88
| -12% | -$2.1K | ﹤0.01% | 3217 |
|
|
2020
Q4 | $17K | Hold |
726
| – | – | ﹤0.01% | 3157 |
|
|
2020
Q3 | $16K | Sell |
726
-241
| -25% | -$5.41K | ﹤0.01% | 3045 |
|
|
2020
Q2 | $22K | Buy |
967
+186
| +24% | +$3.99K | ﹤0.01% | 3027 |
|
|
2020
Q1 | $17K | Sell |
781
-321
| -29% | -$7.64K | ﹤0.01% | 2962 |
|
|
2019
Q4 | $26K | Buy |
1,102
+182
| +20% | +$4.25K | ﹤0.01% | 3105 |
|
|
2019
Q3 | $19K | Hold |
920
| – | – | ﹤0.01% | 3155 |
|
|
2019
Q2 | $19K | Buy |
920
+391
| +74% | +$9.21K | ﹤0.01% | 3213 |
|
|
2019
Q1 | $15K | Hold |
529
| – | – | ﹤0.01% | 3177 |
|
|
2018
Q4 | $13K | Hold |
529
| – | – | ﹤0.01% | 3215 |
|
|
2018
Q3 | $20K | Hold |
529
| – | – | ﹤0.01% | 3201 |
|
|
2018
Q2 | $11K | Buy |
+529
| New | +$9.35K | ﹤0.01% | 3291 |
|
|
2017
Q1 | – | Sell |
-171
| Closed | -$2K | – | 3269 |
|
|
2016
Q4 | $2K | Buy |
+171
| New | +$1.84K | ﹤0.01% | 3280 |
|
Other funds holding IRMD
CCM
NTCM
Legal & General Group's IRMD Position: Q2 2026 in Review
Legal & General Group increased its iRadimed (IRMD) stake by 1.4% in Q2 2026, buying an estimated $8.56K and bringing the position to 6,685 shares worth $639K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.
Legal & General Group first reported a position in IRMD in Q4 2016 and has held it in 34 quarters since. The position peaked at $776K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Legal & General Group held 6,685 shares of iRadimed worth $639K as of Q2 2026.
- Legal & General Group bought 94 iRadimed shares in Q2 2026, an estimated $8.56K.
- iRadimed made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2323 holding.
- Legal & General Group first reported a position in iRadimed in Q4 2016 and has held it in 34 quarters since.
- Legal & General Group's iRadimed position peaked at $776K in Q4 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.